- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Malignant Germ Cell Tumor in Belgium
Total 375 results
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
-
Universitair Ziekenhuis BrusselCompletedRecurrent Glioblastoma (WHO-Grade IV Glioma)Belgium
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsSwitzerland, Italy, Belgium, Germany, Netherlands
-
Epizyme, Inc.Sponsor GmbHRecruitingHepatic Impairment | Advanced Malignant Solid TumorFrance, Belgium, United States, Poland, Slovakia
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Nouscom SRLActive, not recruitingMelanoma (Skin) | Non-Small-Cell Lung CarcinomaBelgium, Spain, United Kingdom
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Glioblastoma Multiforme | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of Brain | Astrocytoma of Brain | Astrocytoma, MalignantUnited States, Germany, Netherlands, Switzerland, Belgium
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Assistance Publique - Hôpitaux de ParisRecruitingInitial Radiological Diagnosis Eligible for Tumor Resection | Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) | Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant TemozolomideBelgium, France, Switzerland
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, Belgium, Germany, Italy, United Kingdom, Netherlands
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
Novartis PharmaceuticalsCompletedAcromegaly | Carcinoid TumorGermany, Belgium, Canada, Netherlands, United States, Norway
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Belgium, Canada, Germany, Spain
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Germany, Belgium, Netherlands, United Kingdom, Italy, Portugal, Austria
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
European Organisation for Research and Treatment...ETOP IBCSG Partners FoundationCompletedSPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic MalignancySpain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
-
Eli Lilly and CompanyNew Approaches to Neuroblastoma Therapy Consortium (NANT); Innovative Therapies...Active, not recruitingNeuroblastomaUnited States, Spain, Australia, Belgium, Japan, France, Germany, Italy, United Kingdom
-
Centre Hospitalier Universitaire Dinant Godinne...Not yet recruitingHead and Neck Squamous Cell Carcinoma | Tumor GrowthBelgium
-
RayzeBio, Inc.Active, not recruitingNeuroendocrine Tumors | Carcinoid Tumor | Gastroenteropancreatic Neuroendocrine Tumor | Carcinoid | GEP-NET | Gastroenteropancreatic Neuroendocrine Tumor Disease | Pancreatic NETCanada, Spain, United States, Netherlands, Belgium, France, Brazil
-
University of LeicesterUnknownBrain and Central Nervous System TumorsUnited Kingdom, Belgium, Germany, Netherlands, France, Sweden, Italy, Spain
-
Boehringer IngelheimRecruitingGlioblastomaBelgium, Spain, United States
-
University of LeicesterUnknownNeuroblastomaIreland, United Kingdom, France, Switzerland, Austria, Italy, Spain, Norway, Belgium, Denmark, Israel, Portugal, Sweden
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; University of California, San Francisco; Medical Center HaaglandenRecruitingGlioblastomaUnited States, Belgium, Germany, Netherlands, Switzerland
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Universitätsklinikum Hamburg-EppendorfDeutsche KinderkrebsstiftungActive, not recruitingBrain TumorsGermany, Denmark, United Kingdom, Belgium, Poland, Ireland, Austria, Italy, Czechia, France, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Astrocytoma, Grade III | High-grade Glioma | Astrocytoma, Grade IV | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Brain Neoplasm, Primary | Brain Neoplasm, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Belgium, Switzerland, Netherlands
-
Delcath Systems Inc.IQVIA BiotechCompletedMelanoma, OcularUnited States, Spain, Italy, Germany, United Kingdom, Switzerland, Belgium, Austria, France
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Jasper GerritsenUniversity Medical Center Groningen; University Hospital, Ghent; Medical Center... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | Astrocytoma, Grade IV | Glioblastoma Multiforme of BrainNetherlands, Belgium
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
CureVacActive, not recruitingGlioblastomaBelgium, Germany, Netherlands
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Belgium, Finland, Austria, Ireland, Sweden, Switzerland, United Kingdom, Germany, Norway
-
Basilea PharmaceuticaCompletedNeoplasmsBelgium, United Kingdom, Germany, Switzerland
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsFrance, Spain, Belgium, Netherlands, Switzerland, Italy
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsFrance, Italy, Belgium, Netherlands, United Kingdom